Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet
NCT04363710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2020-04-27
Summary
T2DM, a chronic progressive disorder has an epidemic status in India. Remission (HbA1c of \< 6.5% without any anti-diabetic medication) of T2DM is achievable with diet modifications in recently diagnosed obese T2D individuals. Studies suggest Very Low Calorie Diet (600 - 800kcal) and Low Calorie Diet-LCD (800 -1000 kcal) using Meal replacers (MR) are helpful. The investigators aimed to study the effects of LCD without any anti diabetic medication in intervention group and later comparing it with Control group (on standard medical treatment).
Conditions
- Type 2 Diabetes Mellitus in Obese
Interventions
- OTHER
-
Low Calorie Diet
800-1000 Kcal/day
Sponsors & Collaborators
-
Max Healthcare Insititute Limited
lead OTHER
Principal Investigators
-
Sujeet Jha, MRCP · Prinicipal Director, Institute of Endocrinology & Metabolism, Maxhealthcare
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-31
- Primary Completion
- 2018-06-01
- Completion
- 2018-11-07
Countries
- India
Study Locations
More Related Trials
-
Short-term Effect of Intensive Insulin Therapy on Incretin Secretion
NCT00776243 ·Status: COMPLETED
-
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
NCT05606471 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 Diabetes
NCT02984605 ·Status: UNKNOWN ·Phase: NA
-
Glucolipotoxicity and Type 2 Diabetes
NCT01375270 ·Status: COMPLETED ·Phase: NA
-
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
NCT05330247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
NCT02987335 ·Status: COMPLETED
-
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
NCT06934707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study About Adherence and Tolerance of an Oral Nutritional Supplement (ONS) Specific for Diabetic Patient.
NCT05488210 ·Status: UNKNOWN
-
Early Diabetes Intervention Program
NCT01470937 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
NCT04027023 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes
NCT00810823 ·Status: COMPLETED
-
Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes
NCT00834626 ·Status: COMPLETED ·Phase: NA
-
Diabetes Intervention Accentuating Diet and Enhancing Metabolism
NCT03225339 ·Status: COMPLETED ·Phase: NA
-
GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients.
NCT04105608 ·Status: COMPLETED ·Phase: NA
-
Retrospective, Multicenter, Single-arm, Observational Study, With Data From Patients With T2DM With Malnutrition or at Risk, Who Were Prescribed Resource® Diabet Plus as a Hypercaloric and Hyperproteic Specific Formula for Patients With T2DM
NCT06866366 ·Status: COMPLETED
-
Endothelial Function in Patients With Type 2 Diabetes Versus Healthy Subjects
NCT01946347 ·Status: COMPLETED ·Phase: NA
-
Residual Insulin Secretion in Patients With Type 1 Diabetes Under a Low Carbohydrate Diet or a Ketogenic Diet
NCT05536232 ·Status: UNKNOWN ·Phase: NA
-
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
NCT06461377 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
NCT04118374 ·Status: COMPLETED ·Phase: NA
-
Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients
NCT01588743 ·Status: UNKNOWN ·Phase: NA
-
Treatment of GLP-1 for Diabetic Bariatric Patients
NCT04624672 ·Status: TERMINATED ·Phase: PHASE4
-
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
NCT07272343 ·Status: RECRUITING ·Phase: PHASE4
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2